Male infertility related to an aberrant karyotype, 46,XY,9ph,9qh+.

Fertil Steril

Genetics and Human Reproduction Division, Gynecology and Obstetric Department, Santo André, Brazil.

Published: June 2009

Objective: To report a man with primary infertility and variant karyotype.

Design: Case report.

Setting: Private practice.

Patient(s): A 37-year-old man with 4 years of primary infertility due to oligoasthenozoospermia.

Intervention(s): None.

Main Outcome Measure(s): G- and C-banding. Polymerase chain reaction for SRY, DBY, RBMY, DAZ, AMELX, and AMELY.

Result(s): G-band analysis of the proband revealed a 46,XY,9ph,9qh+ karyotype. C-banding confirmed increase in the heterochromatin in one chromosome 9 and inversion in the other.

Conclusion(s): The morphologic difference between the homologous chromosomes 9 may have been responsible for an error in crossing-over, leading to aberrant spermatozoa and consequently to infertility.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.fertnstert.2008.10.057DOI Listing

Publication Analysis

Top Keywords

primary infertility
8
male infertility
4
infertility aberrant
4
aberrant karyotype
4
karyotype 46xy9ph9qh+
4
46xy9ph9qh+ objective
4
objective report
4
report man
4
man primary
4
infertility variant
4

Similar Publications

Microprolactinoma Growth During Pregnancy With Pituitary Tumor Apoplexy: Case Report and Review of the Literature.

Case Rep Endocrinol

January 2025

Unidad Académica de Endocrinología y Metabolismo, Hospital de Clínicas "Dr. Manuel Quíntela", Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.

Prolactinomas are the most prevalent subtype of pituitary adenomas and represent one of the leading etiological factors responsible for amenorrhea and infertility in women. The primary therapeutic approach entails the use of dopamine agonists, which effectively restore fertility. In cases of microprolactinomas, the likelihood of experiencing a symptomatic enlargement of the tumor during pregnancy is exceptionally low, estimated at a mere 2.

View Article and Find Full Text PDF

Background: Sperm extraction by Microscopic Testicular Sperm Extraction (microTESE) has become the standard of care for sperm retrieval (SR) in men with non-obstructive azoospermia (NOA) but is costly and has a 40-50% chance of failure. Fine needle aspiration mapping (FNAM) can be performed prior to microTESE as a predictor of success to reduce the likelihood of failure to retrieve sperm but there is limited evidence that directly compares these methods. The objective of this study was to compare success rate of SR, pregnancy, and live birth rates in men who underwent upfront microTESE versus FNAM.

View Article and Find Full Text PDF

Objective: To report on complications of conisation and its effects on fertility and stenosis.

Design: Register based nationwide cohort study on routinely collected data using several linked databases.

Setting: Primary and secondary care in Denmark, 2006-18.

View Article and Find Full Text PDF

Introduction: Dysmenorrhea and heavy menstrual bleeding are the most common symptoms in adenomyosis, in addition to infertility and chronic pelvic pain. Hysterectomy is a common treatment for adenomyosis symptoms with curative effect on heavy menstrual bleeding but with less studied effects on pain reduction.

Material And Methods: This is a nationwide retrospective register-based cohort study including all hysterectomized patients with pathology-verified adenomyosis between 1 January 2012 and 31 December 2015 with a long-term follow-up three years pre- and three years postoperatively.

View Article and Find Full Text PDF

In women after hematopoietic stem cell transplantation (HSCT), complications associated with the original disease and therapies used both before and after transplantation often occur, which significantly affects their quality of life. The most common gynaecological complications include secondary cancers, premature ovarian insufficiency (POI), infertility and chronic graft-versus-host disease (cGVHD). Cervical cancer is the most common secondary genital cancer in patients after HSCT.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!